Orthobiologics are treatments that use biological materials—often a patient’s own blood, bone marrow, or fat—to support the healing of bones, joints, tendons, and ligaments. They are increasingly discussed for musculoskeletal conditions, including bone-softening disorders such as osteomalacia, but they are not a cure-all. This guide explains the main types of orthobiologics, what they are used for, the realistic benefits and risks, and what current evidence supports, so you can have an informed conversation with your clinician.
What Are Orthobiologics?
Orthobiologics are biological substances used to help injured or diseased musculoskeletal tissues heal. The underlying idea is to concentrate or deliver cells, growth factors, or scaffolding materials to the area that needs repair, with the goal of supporting the body’s own repair processes rather than replacing them.
Many orthobiologic products are derived from the patient’s own body (autologous), which lowers the risk of allergic reaction or disease transmission. Others are donor-based (allogeneic) or synthetic. They are typically delivered by injection in a clinic setting or applied directly during surgery.
It is important to understand that orthobiologics are a supporting tool, not a replacement for treating the underlying cause of a condition. For example, in osteomalacia, the core problem is usually a deficiency in vitamin D, calcium, or phosphate metabolism, and that must be corrected first. No biologic injection can substitute for fixing a metabolic deficit.
Orthobiologics also differ from conventional drugs in how they are regulated and studied. Many are prepared at the point of care, which means the final product can vary from one preparation to another. That variability is one reason the evidence base is uneven and why the specific product, its processing, and the condition being treated all matter when judging whether a treatment is appropriate.
Main Types of Orthobiologics
Several categories of orthobiologic products are used or studied in musculoskeletal care. Each has a different composition, preparation method, and purpose, and each carries its own evidence profile.
Platelet-Rich Plasma (PRP)
PRP is made by taking a sample of the patient’s blood and spinning it in a centrifuge to concentrate platelets and the growth factors they release. The concentrated product is then injected into or around the injured tissue.
PRP is one of the most widely used orthobiologics. Its appeal is that it is prepared from the patient’s own blood and is generally well tolerated. However, results vary by preparation method, platelet concentration, activation technique, and the condition being treated. Not all PRP products are equivalent, which complicates comparisons across studies and across clinics.
Bone Marrow Aspirate Concentrate (BMAC)
BMAC involves taking bone marrow, usually from the pelvis, and concentrating the cells and growth factors it contains. It includes mesenchymal stem cells and other progenitor cells along with signaling molecules that may support repair.
It is used in some orthopedic procedures and is being studied for cartilage, tendon, and bone healing. The number and activity of cells can vary between individuals and between preparation techniques, which affects how consistent the final product is. Because of this variability, the same procedure performed at two different clinics may not deliver equivalent material.
Adipose (Fat) Tissue and Cell Products
Fat tissue is another source of mesenchymal cells and growth factors. Adipose-derived products are harvested through liposuction and processed for injection or surgical use.
These products are studied for soft tissue and cartilage repair. Regulation and processing standards vary widely, so it is important to confirm exactly what is being used and how it was prepared. Some adipose products are minimally manipulated, while others undergo extensive processing; the two are not interchangeable and may fall under different regulatory categories.
Mesenchymal Stem Cell (MSC) Therapies
MSC therapies aim to deliver cells that can support tissue repair and modulate inflammation. In routine orthopedic practice, most are derived from bone marrow or fat and are minimally manipulated.
Many clinics advertise “stem cell” treatments, but the evidence for many uses is still developing, and marketing language often outpaces the science. Ask specifically what cells are used, their source, how they are processed, and whether the product is approved or part of a regulated study. A clear answer to these questions is a useful signal of a trustworthy practice.
Bone Grafts and Bone Graft Substitutes
Bone grafts provide a scaffold and biological stimulus to help new bone form. They can be autografts (from the patient’s own body), allografts (from donors), or synthetic substitutes.
These are commonly used in fracture repair, spinal fusion, and procedures where bone needs to regrow. They are well established in many surgical settings and represent the most mature area of orthobiologic practice. Each graft type has trade-offs in terms of supply, cost, and the risk of complications, which surgeons weigh case by case.
Growth Factors and Biologic Adjuncts
Growth factors are proteins that signal cells to grow, divide, and repair tissue. Some are delivered within PRP or BMAC, while others are used as specific products in surgery.
Their use is often targeted and procedure-specific. Evidence varies widely by product, and they are usually part of a broader treatment plan rather than a standalone solution. Because growth factors act in complex networks, isolating a single factor does not always reproduce the effects of the body’s natural repair signaling.
How Orthobiologics Are Used in Practice
Orthobiologics are applied across a range of musculoskeletal conditions, usually after simpler treatments have been considered. The setting matters: some are used in clinic injections, others during surgery.
- Tendon injuries such as tennis elbow, Achilles tendinopathy, and rotator cuff problems
- Ligament sprains and partial tears
- Cartilage defects and early osteoarthritis
- Muscle strains and soft tissue injuries
- Bone healing support in fractures and fusion procedures
- Supporting recovery after certain orthopedic surgeries
For people with bone-softening conditions like osteomalacia, orthobiologics are not the primary treatment. The priority is correcting the metabolic cause, such as vitamin D or phosphate deficiency, and preventing fractures. Orthobiologics might only be considered in specific fracture-healing situations under specialist guidance.
In practice, orthobiologics are rarely used in isolation. They are typically combined with physical therapy, activity modification, load management, and other standard care. The biologic is intended to complement rehabilitation and recovery, not to replace the work of rebuilding strength and function.
Benefits: What Orthobiologics Can Offer
The potential benefits depend heavily on the product, the condition, and the patient. Not every advertised benefit is supported by strong evidence, and the gap between marketing and proven benefit can be wide.
- Uses the patient’s own biological material in many cases, reducing allergy and transmission concerns
- May support the body’s natural healing response in certain tendon and joint conditions
- Often minimally invasive when delivered by injection
- Generally shorter recovery compared with open surgery for injection-based treatments
- Can be combined with other treatments as part of a broader plan
- Some products are well established in bone healing and surgical settings
A realistic view is that benefits are often modest and variable. Some patients improve, while others see little change. Setting expectations with a clinician before treatment is essential, and it is reasonable to ask what proportion of patients with a similar condition experience meaningful improvement.
Risks and Limitations
Orthobiologics are generally considered low-risk when prepared and used appropriately, but they are not risk-free. Understanding limitations helps patients make a balanced decision.
- Pain, swelling, or bruising at the injection or harvest site
- Infection, especially with any injection or procedure
- Variable results because product quality and cell counts can differ
- Limited or mixed evidence for many uses, especially for arthritis and cartilage repair
- Cost, which is often not covered by insurance
- Risk of unproven claims from clinics offering unregulated products
- Not a substitute for treating underlying conditions such as osteomalacia
Be cautious of any provider promising guaranteed regrowth of cartilage or a cure for joint disease. Regulated oversight and honest counseling are signs of a trustworthy practice. A clinician who explains uncertainty clearly is generally more reliable than one who promises specific outcomes.
What the Evidence Says
The evidence for orthobiologics is uneven. Some applications have a reasonable body of research, while others rely on small studies or anecdotal reports. The strength of evidence also depends on the outcome being measured: pain relief, functional improvement, and structural tissue change are different endpoints, and a treatment may affect one without affecting the others.
PRP has been studied extensively for tendon problems, with mixed but generally encouraging results in some conditions. Bone grafts are well established in surgery. Evidence for stem cell and adipose products is still developing, and many questions remain about optimal dosing, cell counts, and preparation methods. Because research evolves, patients should ask their clinician what the current evidence is for their specific condition. A treatment that works for one tendon may not work for another, and results from one preparation method may not apply to a different product.
It also helps to understand the difference between regulatory approval and clinical evidence. A product may be legally marketed without having been proven effective for a particular use, so approval status alone does not confirm benefit. Asking both questions—what is approved and what is proven—gives a fuller picture.
Orthobiologics and Osteomalacia: What to Know
Osteomalacia is a bone-softening disorder usually caused by problems with vitamin D, calcium, or phosphate. The cornerstone of treatment is correcting the underlying deficiency and monitoring bone health, often with laboratory testing and imaging over time.
Orthobiologics do not treat the metabolic cause of osteomalacia. They may only be relevant in specific situations, such as supporting fracture healing, and only under specialist care. The distinction matters because delaying proven metabolic treatment in favor of injections can allow bone weakness to progress.
- Focus first on nutritional and metabolic correction as advised by a doctor
- Address fall prevention and fracture risk
- Discuss any biologic treatment with a specialist who understands the bone condition
- Do not delay proven treatment in favor of unproven injections
For bone-softening conditions, correcting the underlying cause remains the most important step. Orthobiologics are not a substitute for that care.
Comparison at a Glance
The table below summarizes common orthobiologic types and their typical roles. It is a general guide, not medical advice.
| Type | Source | Common Uses | Evidence Strength |
|---|---|---|---|
| Platelet-Rich Plasma (PRP) | Patient’s blood | Tendon injuries, some joint conditions | Mixed to moderate for select uses |
| Bone Marrow Aspirate Concentrate | Patient’s bone marrow | Bone, cartilage, tendon support | Developing |
| Adipose-derived products | Patient’s fat tissue | Soft tissue and cartilage research | Limited |
| Bone grafts and substitutes | Self, donor, or synthetic | Fracture repair, spinal fusion | Well established |
| Growth factor products | Various | Surgical and targeted repair | Varies by product |
How to Decide If Orthobiologics Are Right for You
Choosing an orthobiologic treatment should be a shared decision with a qualified clinician. Consider the diagnosis, personal goals, and alternatives before committing to a procedure.
- Confirm the diagnosis and whether the underlying cause is being treated
- Ask what specific product will be used and how it is prepared
- Request the evidence for the exact condition being treated
- Understand the realistic expected benefit and timeline
- Review risks, costs, and insurance coverage
- Check the provider’s qualifications and regulatory oversight
- Ask about alternatives, including physical therapy and standard care
A good clinician will welcome these questions and will not pressure a patient into a quick decision. It is also reasonable to seek a second opinion, particularly when a treatment is expensive, unproven, or being marketed aggressively.
Practical Questions to Ask Your Provider
Being prepared for an appointment helps patients get clear answers. These questions apply to most orthobiologic treatments.
- What exactly is being injected or used, and where does it come from?
- Is this treatment approved, and what does the evidence show for my condition?
- What are the alternatives, and how do they compare?
- What are the possible side effects and how are they managed?
- How many sessions might be needed, and what is the total cost?
- What results are realistic, and when would a change be noticeable?
Conclusion
Orthobiologics offer a promising but uneven field of treatments that use biological materials to support healing. Some, like bone grafts, are well established, while others, like stem cell and adipose products, are still being studied. They can be helpful in selected musculoskeletal conditions but are not a cure-all, and they do not replace treatment of underlying causes such as osteomalacia. The best approach is an informed one: confirm the diagnosis, ask about the evidence for the specific situation, and work with a qualified clinician to weigh benefits, risks, and costs.
Frequently Asked Questions
Are orthobiologics safe?
Most orthobiologics that use a patient’s own tissue are generally well tolerated, with common side effects like pain or swelling at the treatment site. Any injection or procedure carries a small risk of infection or other complications. Safety also depends on how the product is prepared and by whom, so choosing a qualified, regulated provider matters.
Do orthobiologics regrow cartilage?
There is no strong evidence that current orthobiologics reliably regrow cartilage in humans. Some studies suggest modest improvements in symptoms for certain patients, but regrowth claims are often overstated. Discuss realistic goals with a clinician rather than expecting a full rebuild of joint tissue.
Can orthobiologics treat osteomalacia?
No. Osteomalacia is caused by problems with vitamin D, calcium, or phosphate metabolism, and treatment focuses on correcting those issues. Orthobiologics do not fix the metabolic cause. They might only be considered in specific fracture-healing situations under specialist guidance.
How long does it take to notice results?
Timelines vary by product and condition. Some people notice changes within weeks, while others may take several months or see no meaningful difference. A clinician can give a realistic timeline based on the specific treatment and diagnosis.
Are orthobiologics covered by insurance?
Coverage varies widely. Many orthobiologic injections are considered elective or investigational and are not covered, meaning patients may pay out of pocket. Surgical bone grafts are more often covered when medically necessary. Check with the insurer and provider before treatment.
What is the difference between PRP and stem cell therapy?
PRP is a concentrate of platelets and growth factors from the patient’s blood. Stem cell therapies aim to deliver cells, often from bone marrow or fat, that may support repair. They are different products with different evidence bases, and “stem cell” marketing can be misleading, so ask exactly what is being used.
How many orthobiologic injections will I need?
The number depends on the condition and the product. Some tendon treatments use a single injection, while others may involve a series. A provider should explain the planned schedule, expected costs, and what happens if there is no improvement.
Can orthobiologics be combined with other treatments?
Yes, they are often used alongside physical therapy, activity modification, and standard medical care. Combining treatments can be reasonable, but each should be justified. Avoid replacing proven care, such as correcting a vitamin D deficiency, with unproven injections.
What should I look for in a clinic offering orthobiologics?
Look for a qualified clinician who explains the evidence honestly, uses regulated preparation methods, and does not make guaranteed claims. Ask about experience, the product source, and oversight. Be wary of aggressive marketing or pressure to pay upfront for unproven treatments.
Are donor-based orthobiologics available?
Some products, such as certain bone grafts, come from donors and are well established in surgery. Other donor-based biologic products exist but have varying levels of evidence and regulation. Ask a provider about the source, screening, and approval status of any donor product.
